D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 62 Citations 10,239 285 World Ranking 2192 National Ranking 189

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • Cancer

Hans J. Stauss mainly focuses on Cytotoxic T cell, Immunology, Antigen, Molecular biology and T-cell receptor. His Cytotoxic T cell research includes elements of Epitope, T cell and Virology. He combines subjects such as Penetrance and Cancer research with his study of Immunology.

His studies in Antigen integrate themes in fields like Genetic enhancement and Immunotherapy. His study focuses on the intersection of Molecular biology and fields such as Major histocompatibility complex with connections in the field of Peptide. Hans J. Stauss has researched T-cell receptor in several fields, including In vitro, T lymphocyte, CD3, CD8 and Tumor antigen.

His most cited work include:

  • Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1. (407 citations)
  • Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. (375 citations)
  • Deleterious Mutations in LRBA Are Associated with a Syndrome of Immune Deficiency and Autoimmunity (321 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Immunology, Cytotoxic T cell, Antigen, T-cell receptor and T cell. His Immunology study focuses mostly on Immunotherapy, Immune system, Adoptive cell transfer, Antigen-presenting cell and Leukemia. His biological study spans a wide range of topics, including Molecular biology, Cancer research, CD8 and Major histocompatibility complex.

His Antigen research is multidisciplinary, relying on both Gene, Tumor antigen and Wilms' tumor. The concepts of his T-cell receptor study are interwoven with issues in Gene transfer, CD3, Genetic enhancement, Cell biology and Chimeric antigen receptor. His Epitope research incorporates themes from Immunogenicity and Virology.

He most often published in these fields:

  • Immunology (48.36%)
  • Cytotoxic T cell (36.51%)
  • Antigen (29.93%)

What were the highlights of his more recent work (between 2015-2021)?

  • Immunology (48.36%)
  • T-cell receptor (26.97%)
  • Cancer research (20.07%)

In recent papers he was focusing on the following fields of study:

Hans J. Stauss focuses on Immunology, T-cell receptor, Cancer research, Immune system and T cell. His Immunology study combines topics in areas such as Cytotoxic T cell and Penetrance. His T-cell receptor research incorporates elements of Avidity, Antigen, Genetic enhancement, Cell biology and Chimeric antigen receptor.

Hans J. Stauss works mostly in the field of Antigen, limiting it down to concerns involving Antibody and, occasionally, Lytic cycle. His Cancer research study integrates concerns from other disciplines, such as Downregulation and upregulation, Stem cell, Cell therapy and Immunotherapy. His T cell research includes themes of Renal transplant and Immune status.

Between 2015 and 2021, his most popular works were:

  • Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans (77 citations)
  • The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1 (70 citations)
  • Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations (55 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Cancer

His primary scientific interests are in Immunology, T cell, Cell biology, Primary immunodeficiency and Common variable immunodeficiency. His work carried out in the field of Immunology brings together such families of science as Transplantation and Risk factor. His research integrates issues of Immune status, CD8 and Cancer immunotherapy in his study of T cell.

His Cell biology study combines topics from a wide range of disciplines, such as Immunotherapy, Adoptive cell transfer and T-cell receptor. His research in T-cell receptor intersects with topics in Antigen and Effector. His work in Immune system tackles topics such as Receptor expression which are related to areas like Cytotoxic T cell and Virus.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1.

Liquan Gao;Ilaria Bellantuono;Annika Elsässer;Stephen B. Marley.
Blood (2000)

553 Citations

Deleterious Mutations in LRBA Are Associated with a Syndrome of Immune Deficiency and Autoimmunity

Gabriela Lopez-Herrera;Giacomo Tampella;Qiang Pan-Hammarström;Peer Herholz.
American Journal of Human Genetics (2012)

478 Citations

Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer.

Thomas Stanislawski;Ralf-Holger Voss;Carina Lotz;Elena Sadovnikova.
Nature Immunology (2001)

470 Citations

Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice

Julia Yuen-Shan Tsang;Yakup Tanriver;Shuiping Jiang;Shao-An Xue.
Journal of Clinical Investigation (2008)

259 Citations

Isolation of endothelial cells from murine tissue.

Federica M Marelli-Berg;Emma Peek;Elaine A Lidington;Hans J Stauss.
Journal of Immunological Methods (2000)

243 Citations

Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells.

Shao-An Xue;Liquan Gao;Daniel Hart;Roopinder Gillmore.
Blood (2005)

241 Citations

Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis.

Graham P. Wright;Clare A. Notley;Shao-An Xue;Gavin M. Bendle.
Proceedings of the National Academy of Sciences of the United States of America (2009)

221 Citations

Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines

Adam J. Gehring;Shao-An Xue;Zi Zong Ho;Denise Teoh.
Journal of Hepatology (2011)

207 Citations

Regulatory T cells, derived from naïve CD4+CD25- T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance.

Jian-Guo Chai;Shao-an Xue;David Coe;Caroline Addey.
Transplantation (2005)

195 Citations

Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: Reagents for tumor immunotherapy

Elena Sadovnikova;Hans J. Stauss.
Proceedings of the National Academy of Sciences of the United States of America (1996)

189 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Hans J. Stauss

Antonio Bertoletti

Antonio Bertoletti

Duke NUS Graduate Medical School

Publications: 66

Wolfgang Uckert

Wolfgang Uckert

Max Delbrück Center for Molecular Medicine

Publications: 59

Haruo Sugiyama

Haruo Sugiyama

Osaka University

Publications: 58

Bodo Grimbacher

Bodo Grimbacher

University of Freiburg

Publications: 47

Giovanna Lombardi

Giovanna Lombardi

King's College London

Publications: 46

Robert I. Lechler

Robert I. Lechler

King's College London

Publications: 44

Yoshihiro Oka

Yoshihiro Oka

Osaka University

Publications: 42

Anne Puel

Anne Puel

Université Paris Cité

Publications: 38

Stanley R. Riddell

Stanley R. Riddell

University of Washington

Publications: 38

Ton N. M. Schumacher

Ton N. M. Schumacher

Antoni van Leeuwenhoek Hospital

Publications: 35

Thomas Blankenstein

Thomas Blankenstein

Max Delbrück Center for Molecular Medicine

Publications: 34

Nima Rezaei

Nima Rezaei

Tehran University of Medical Sciences

Publications: 34

David A. Scheinberg

David A. Scheinberg

Memorial Sloan Kettering Cancer Center

Publications: 33

Steven A. Rosenberg

Steven A. Rosenberg

National Institutes of Health

Publications: 32

David Price

David Price

University of Aberdeen

Publications: 31

Philip D. Greenberg

Philip D. Greenberg

Fred Hutchinson Cancer Research Center

Publications: 31

Trending Scientists

Greg F. Naterer

Greg F. Naterer

Memorial University of Newfoundland

Matteo Pastorino

Matteo Pastorino

University of Genoa

Luc Vereecken

Luc Vereecken

Max Planck Society

Xin Lin

Xin Lin

Northwestern Polytechnical University

Brian S. Swartzentruber

Brian S. Swartzentruber

Sandia National Laboratories

Jun-Ichi Hayashi

Jun-Ichi Hayashi

University of Tsukuba

Judy A. Stamps

Judy A. Stamps

University of California, Davis

Roberto Iglesias-Prieto

Roberto Iglesias-Prieto

Pennsylvania State University

François Penin

François Penin

Claude Bernard University Lyon 1

Martin T. Orne

Martin T. Orne

University of Pennsylvania

Toshiharu Ninomiya

Toshiharu Ninomiya

Kyushu University

Israel Penn

Israel Penn

University of Cincinnati

Mark Lebwohl

Mark Lebwohl

Icahn School of Medicine at Mount Sinai

Serge Guimond

Serge Guimond

University of Clermont Auvergne

Stefan Kuhlmann

Stefan Kuhlmann

University of Twente

Something went wrong. Please try again later.